Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

At the University of Minnesota, researchers keep hearts alive outside the body for hours. Medtronic uses them to develop ...

In a report released today, Matthew O’Brien from Piper Sandler maintained a Hold rating on Medtronic (MDT – Research Report), with a price ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

In the most recent trading session, Medtronic (MDT) closed at $91.99, indicating a +0.63% shift from the previous trading day.

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even ...

Neko Health has raised $260 million to expand a preventative healthcare service designed to detect cancers, cardiovascular ...

UroMems, a global medical technology company developing the first smart automated implant to treat stress urinary incontinence (SUI), ...

What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission, Martha, Chairman and CEO at Medtronic, executed a strategic derivative sale. This involved ...

What Happened: The latest Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission uncovered Walter, SVP at Medtronic, exercising stock options for 1,337 shares of MDT. The total ...

Medtronic PLC (BVMF:MDTC34) (MDT), a global leader in medical technology, services, and solutions, has reached a new 52-week ...